Conan MedTech
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Conan MedTech - overview
Established
2020
Location
Ithaca, NY, US
Primary Industry
Medical Devices & Equipment
About
Based in New York, US, and founded in 2020 by CTO Bayan A. Alturkestani, Conan MedTech Corp. , a. k.
a. Conan MedTech provides rapid POC (point-of-care) diagnostic tests, enabling sport medicine doctors, athletic coaches, and trainers to make decisions at the sideline during a game. In January 2022, Conan MedTech raised an undisclosed amount of seed funding from new investor SOSV. The company’s product line includes POC (point-of-care) diagnostic test, a lateral flow device that uses specific monoclonal antibodies to recognize neuronal biomarkers that show up in saliva immediately after traumatic brain injury.
Current Investors
SOSV
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Diagnostic Equipment
Website
www.conanmedtech.com
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Conan MedTech - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.